Practice Test Geeks(CTA) Clinical Trial Associate Certification Practice Test
← All CTA Flashcard Decks

Trial Procedures Flashcards

7 cards from real CTA practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Trial Procedures flashcards as text

  1. What is the significance of the 'visit window' defined in a clinical trial protocol?

    Answer: It specifies the acceptable time range around a scheduled visit date within which the visit can occur while remaining protocol-compliant

    Visit windows define the allowable time range around a target visit date so that assessments remain scientifically valid and protocol-compliant.

  2. Which of the following is an example of a serious adverse event (SAE) as defined by ICH E6?

    Answer: Hospitalization for a condition unrelated to the study drug

    Any hospitalization, whether or not related to the study drug, meets the ICH E6 definition of a serious adverse event.

  3. What does 'protocol adherence' mean in the context of a clinical trial?

    Answer: Conducting all trial activities in strict accordance with the approved protocol

    Protocol adherence means that all procedures, assessments, and timelines specified in the approved protocol are followed as written.

  4. In a clinical trial, who is responsible for ensuring that all site staff involved in the trial are adequately trained and qualified?

    Answer: The principal investigator (PI)

    The principal investigator is responsible for ensuring that all delegated site staff are appropriately qualified and trained for their assigned roles.

  5. What is the purpose of the Trial Master File (TMF)?

    Answer: To maintain all essential documents that allow evaluation of the conduct of a trial and quality of data generated

    The TMF contains all essential documents needed to reconstruct the trial and verify that it was conducted in compliance with GCP and regulations.

  6. When a subject withdraws consent and leaves a clinical trial, what must the site staff do regarding the subject's data already collected?

    Answer: Retain the data collected prior to withdrawal unless the subject specifically requests its removal and regulations permit it

    Data collected before withdrawal is generally retained per regulations and the protocol, unless the subject explicitly requests deletion and applicable laws allow it.

  7. What is the CTA's responsibility when a monitoring visit report identifies an action item requiring site response?

    Answer: Review the report, implement corrective actions within the specified timeframe, and document the response

    CTAs must review monitoring reports, take corrective actions promptly within specified timelines, and document all responses to close each action item.